Richmond Pharmacology is delighted to announce the promotion of Samarjit Singh into the position of Director of Clinical Operations.

Samarjit has been part of the Richmond Pharmacology team for more than 16 years, during which he held several positions, including his most recent as Head of Scheduling.

In his new role, Samarjit will bring his years of industry experience and knowledge to drive best practice in (non-medical) clinical operations execution across the company, setting strategic guidance for the clinical operations teams and providing operational direction for the delivery of clinical trials undertaken at Richmond Pharmacology.

The position of Director of Clinical Operations has been developed to reflect the planned growth strategy of Richmond Pharmacology.

On his promotion, Samarjit said: “I’m excited about the opportunity to elevate clinical operations to the next level within Richmond Pharmacology.”

Richmond Pharmacology is a full-service clinical research organisation based in London, UK. Founded in 2001, Richmond Pharmacology is led by its founding directors Dr Jorg Taubel, CEO and Dr Ulrike Lorch, whose experience has been gained in more than 500 clinical trials.

Latest news

Futureproofing early phase clinical research for the next generation of investigators.

March 20, 2023
Richmond Pharmacology’s experienced Principal investigators and Co-investigators recently gave expert feedback on the ICH M11 (CeSHarP) protocol template.
Read more

Director of Operations, Keith Berelowitz, has been appointed as the Research Ethics Committee Chair for the Health Research Authority.

January 19, 2023
Keith Berelowitz will be responsible for ensuring that all ethical possibilities are explored in relation to new research.
Read more


13th International Workshop on Regulatory Requirements and Current Scientific Aspects on the Preclinical and Clinical Investigation of Drug-Drug Interactions

Sunday, June 4th to Tuesday June 6th 2023
Exchange research-based knowledge on drug-drug interactions (DDIs) among all interested stakeholders from pharmaceutical industry, regulatory authorities, academic and health care delivery backgrounds and perspectives.
View event